International Journal of Pharmaceutical Compounding

A subscription to IJPC provides on-line access to full-text, full-color, printable PDF copies of your subscribed issues, individual articles, and purchased archives.

LEARN MORE

Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment

Author(s): Allen Loyd V Jr

Issue: Jan/Feb 2020 - Volume 24, Number 1
View All Articles in Issue

Page(s): 57

Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Page 1

Download in electronic PDF format for $75

Abstract: A formulation for preparing Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment. Includes ingredients, method of preparation, discussion, and references for the compounding pharmacist.

Related Keywords: formulation, hydrocortisone, iodoquinol, metronidazole, zinc oxide, skin disorders, corticosteroid, inflammation, anti-inflammatory agent, amebicide, antibiotic, bacterial infection, antimicrobial agent, topical preparation, dermal protection

Related Categories: DERMATOLOGY, FORMULATIONS, ALLERGY/IMMUNOLOGY/INFLAMMATION, DOSAGE FORMS/DRUG CARRIERS, INFECTIOUS DISEASE

Printer-Friendly Version

Title/Author (Click for Abstract / Details / Purchase)	Issue/Page View/Buy
Related Articles from IJPC
Hydrocortisone 2%, Iodoquinol 1% Metronidazole 10%, and Zinc Oxide 2% in Polyethylene Glycol Ointment Allen Loyd V Jr	Jan/Feb 2020 Pg. 57
Hydrocortisone Hemisuccinate 2 mg/mL or Hydrocortisone Sodium Phosphate 2 mg/mL in SyrSpend SF pH4 Allen Loyd V Jr	Jul/Aug 2020 Pg. 315
Pluronic Lecithin Organogel for Local Delivery of Anti-Inflammatory Drugs Frankum James, Ramsay Dale, Das Nandita G, Das Sudip K	Mar/Apr 2004 Pg. 101-105
Metronidazole 10%, Nifedipine 0.5%, Lidocaine 1.5%, and Diclofenac 3% Ointment Allen Loyd V Jr	Sep/Oct 2022 Pg. 430
Skin Disorders in Horses; Case Report: Tripelennamine in the Treatment of Skin Disorders in Horses Williams LaVonn A, Fokken Dawn	Sep/Oct 2009 Pg. 386-389
Zinc Oxide 20% Gel Allen Loyd V Jr	Sep/Oct 2002 Pg. 365
Wetting and/or Solubilizing Agents, Featured Excipient: Allen Loyd V Jr	Jul/Aug 2001 Pg. 310-312
Enhancement of Skin Penetration of Nonsteroidal Anti-Inflammatory Drugs from Extemporaneously Compounded Topical-Gel Formulations Goodwin Donald A, Fuhram L Clifton	Nov/Dec 1999 Pg. 496-500
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drop Allen Loyd V Jr	May/Jun 1999 Pg. 225
Veterinary Antibiotic/Antifungal/Anti-Inflammatory Anesthetic Otic Drops Hinkle Amanda R, Newton Gail D	May/Jun 2004 Pg. 185
Hydrocortisone 0.5% Ethanolic Gel Allen Loyd V Jr	Sep/Oct 2007 Pg. 423
A Compendium of Compounding Agents and Formulations, Part 2: Metronidazole, Misoprostol, and Phenytoin Riepl Mike	Mar/Apr 2022 Pg. 94-98
Silver Sulfadiazine 1% and Hydrocortisone 2% Gel Allen Loyd V Jr	Sep/Oct 2023 Pg. 422-423
Compounding Pearls--Wound Care: Drugs and Formulations for Dermal Healing, Part 3: The Roles of Nitric Oxide, Sildenafil, and Naltrexone Riepl Mike	Sep/Oct 2021 Pg. 372-377
Management of Psoriasis with a XemaTop Topical Compounded Formula: A Case Report Jones Nat, Carvalho Maria, Branvold-Herr Andrea	May/Jun 2017 Pg. 205-211
Use of Topical Metronidazole in the Treatment of Anorectal Crohn's Disease McElhiney Linda F	Sep/Oct 2013 Pg. 380-383
Zirconium Oxide Lotion Allen Loyd V Jr	Jul/Aug 2008 Pg. 364
Chemical Stability of Hydrocortisone in an Oral Liquid Dosage Form without Suspending Agents Gupta Vishnu D	May/Jun 2007 Pg. 259-261
Lavender Oil 4% in Polyethylene Glycol Ointment Allen Loyd V Jr	Nov/Dec 2011 Pg. 503
Stability of an Alcohol-free, Dye-free Hydrocortisone (2 mg/mL) Compounded Oral Suspension Manchanda Arushi, Laracy Melissa, Savji Taslim, Bogner Robin H	Jan/Feb 2018 Pg. 66-75
Return to Top